| |
|
|
|
LA Jolla Pharma  
|
|
4.0499 0.07 (0.02%) |
10-21 14:10 |
|
Open: |
4.055 |
Pre close: |
3.98 |
Target:
|
5.13 
|
|
High: |
4.08 |
Low: |
3.945 |
Resistance:
|
4.40
4.85
|
|
Volume: |
96,639 |
Market Cap: |
111M |
Support:
|
3.66
3.05
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.00
|
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
4.07  |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
4.35 |
Stochastic Oscillator |
%K(14,3):
|
30.56 |
|
MA(250): |
5.31 |
%D(3): |
34.14 |
|
Average Volume(K) |
3-Month: |
43423
|
52-Week |
High:
|
9.38 |
|
10-Days: |
23721 |
Low: |
2.30 |
|
RSI |
RSI(14):
|
47.05 |
Change(%): |
-48.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.887 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
27.30 |
|
EPS Est. Current Year |
-4.990 |
Return on Assets (ttm) |
-32.6 |
Shares Float (M) |
12.75 |
|
EPS Est. Next Year |
-3.970 |
PEG Ratio |
0.00 |
% Held by Insiders |
5.99 |
|
EPS Est. Next Quarter |
-1.420 |
Qtrly Rev. Growth |
1.8 |
% Held by Institutions |
83.61 |
|
Forward EPS |
-7.850 |
Gross Profit (p.s.) |
0.757 |
Shares Short (K) |
3370 |
|
Book Value (p.s.) |
-2.890 |
EBITDA (p.s.) |
-2.540 |
P/E |
-1.39 |
|
Sales Per Share |
0.965 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-1.39 |
|
Profit Margin |
-298.23 |
Operating Cash Flow
(M) |
-56.34 |
P/S |
4.16 |
|
Operating Margin |
-274.13 |
Levered Free Cash Flow
(M) |
-36.16 |
P/CF |
-1.95 |
|
|
|
|
|
|
